- call +1-201-465-4211
- email sales@mrinsights.biz
Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.
According to this study, over the next five years the Insulin Drug Delivery Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin Drug Delivery Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.
This study considers the Insulin Drug Delivery Devices value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Syringes
Insulin Pens
Jet Injectors
Insulin Pumps
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Homecare
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Insulin Drug Delivery Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Insulin Drug Delivery Devices market by identifying its various subsegments.
Focuses on the key global Insulin Drug Delivery Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insulin Drug Delivery Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Insulin Drug Delivery Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Insulin Drug Delivery Devices Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Drug Delivery Devices Consumption 2014-2024
2.1.2 Insulin Drug Delivery Devices Consumption CAGR by Region
2.2 Insulin Drug Delivery Devices Segment by Type
2.2.1 Syringes
2.2.2 Insulin Pens
2.2.3 Jet Injectors
2.2.4 Insulin Pumps
2.3 Insulin Drug Delivery Devices Consumption by Type
2.3.1 Global Insulin Drug Delivery Devices Consumption Market Share by Type (2014-2019)
2.3.2 Global Insulin Drug Delivery Devices Revenue and Market Share by Type (2014-2019)
2.3.3 Global Insulin Drug Delivery Devices Sale Price by Type (2014-2019)
2.4 Insulin Drug Delivery Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Homecare
2.4.4 Others
2.5 Insulin Drug Delivery Devices Consumption by Application
2.5.1 Global Insulin Drug Delivery Devices Consumption Market Share by Application (2014-2019)
2.5.2 Global Insulin Drug Delivery Devices Value and Market Share by Application (2014-2019)
2.5.3 Global Insulin Drug Delivery Devices Sale Price by Application (2014-2019)
3 Global Insulin Drug Delivery Devices by Players
3.1 Global Insulin Drug Delivery Devices Sales Market Share by Players
3.1.1 Global Insulin Drug Delivery Devices Sales by Players (2017-2019)
3.1.2 Global Insulin Drug Delivery Devices Sales Market Share by Players (2017-2019)
3.2 Global Insulin Drug Delivery Devices Revenue Market Share by Players
3.2.1 Global Insulin Drug Delivery Devices Revenue by Players (2017-2019)
3.2.2 Global Insulin Drug Delivery Devices Revenue Market Share by Players (2017-2019)
3.3 Global Insulin Drug Delivery Devices Sale Price by Players
3.4 Global Insulin Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Insulin Drug Delivery Devices Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Insulin Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Insulin Drug Delivery Devices by Regions
4.1 Insulin Drug Delivery Devices by Regions
4.1.1 Global Insulin Drug Delivery Devices Consumption by Regions
4.1.2 Global Insulin Drug Delivery Devices Value by Regions
4.2 Americas Insulin Drug Delivery Devices Consumption Growth
4.3 APAC Insulin Drug Delivery Devices Consumption Growth
4.4 Europe Insulin Drug Delivery Devices Consumption Growth
4.5 Middle East & Africa Insulin Drug Delivery Devices Consumption Growth
5 Americas
5.1 Americas Insulin Drug Delivery Devices Consumption by Countries
5.1.1 Americas Insulin Drug Delivery Devices Consumption by Countries (2014-2019)
5.1.2 Americas Insulin Drug Delivery Devices Value by Countries (2014-2019)
5.2 Americas Insulin Drug Delivery Devices Consumption by Type
5.3 Americas Insulin Drug Delivery Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Insulin Drug Delivery Devices Consumption by Countries
6.1.1 APAC Insulin Drug Delivery Devices Consumption by Countries (2014-2019)
6.1.2 APAC Insulin Drug Delivery Devices Value by Countries (2014-2019)
6.2 APAC Insulin Drug Delivery Devices Consumption by Type
6.3 APAC Insulin Drug Delivery Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Insulin Drug Delivery Devices by Countries
7.1.1 Europe Insulin Drug Delivery Devices Consumption by Countries (2014-2019)
7.1.2 Europe Insulin Drug Delivery Devices Value by Countries (2014-2019)
7.2 Europe Insulin Drug Delivery Devices Consumption by Type
7.3 Europe Insulin Drug Delivery Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Insulin Drug Delivery Devices by Countries
8.1.1 Middle East & Africa Insulin Drug Delivery Devices Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Insulin Drug Delivery Devices Value by Countries (2014-2019)
8.2 Middle East & Africa Insulin Drug Delivery Devices Consumption by Type
8.3 Middle East & Africa Insulin Drug Delivery Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Insulin Drug Delivery Devices Distributors
10.3 Insulin Drug Delivery Devices Customer
11 Global Insulin Drug Delivery Devices Market Forecast
11.1 Global Insulin Drug Delivery Devices Consumption Forecast (2019-2024)
11.2 Global Insulin Drug Delivery Devices Forecast by Regions
11.2.1 Global Insulin Drug Delivery Devices Forecast by Regions (2019-2024)
11.2.2 Global Insulin Drug Delivery Devices Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Insulin Drug Delivery Devices Forecast by Type
11.8 Global Insulin Drug Delivery Devices Forecast by Application
12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Company Details
12.1.2 Insulin Drug Delivery Devices Product Offered
12.1.3 Novo Nordisk Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Novo Nordisk News
12.2 Sanofi
12.2.1 Company Details
12.2.2 Insulin Drug Delivery Devices Product Offered
12.2.3 Sanofi Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Sanofi News
12.3 BD
12.3.1 Company Details
12.3.2 Insulin Drug Delivery Devices Product Offered
12.3.3 BD Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 BD News
12.4 Eli Lilly
12.4.1 Company Details
12.4.2 Insulin Drug Delivery Devices Product Offered
12.4.3 Eli Lilly Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Eli Lilly News
12.5 Medtronic
12.5.1 Company Details
12.5.2 Insulin Drug Delivery Devices Product Offered
12.5.3 Medtronic Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Medtronic News
12.6 Beta Bionics
12.6.1 Company Details
12.6.2 Insulin Drug Delivery Devices Product Offered
12.6.3 Beta Bionics Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Beta Bionics News
12.7 Dance Biopharm
12.7.1 Company Details
12.7.2 Insulin Drug Delivery Devices Product Offered
12.7.3 Dance Biopharm Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Dance Biopharm News
12.8 Roche
12.8.1 Company Details
12.8.2 Insulin Drug Delivery Devices Product Offered
12.8.3 Roche Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Roche News
12.9 Tandem Diabetes Care
12.9.1 Company Details
12.9.2 Insulin Drug Delivery Devices Product Offered
12.9.3 Tandem Diabetes Care Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Tandem Diabetes Care News
12.10 Animas
12.10.1 Company Details
12.10.2 Insulin Drug Delivery Devices Product Offered
12.10.3 Animas Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Animas News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Insulin Drug Delivery Devices
Table Product Specifications of Insulin Drug Delivery Devices
Figure Insulin Drug Delivery Devices Report Years
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
